B1

Nuntium

De re publica edita documento: ad robora progressionem harum medicinae cogitationes (cum album)

01

Robora et innovative progressionem summus finem cogitationes, comprehendo his genera

111149911ehehdg

Catalogus (MMXXIV Edition) ex tribus genera catalogs: adhortatus, restricted et eliminated.

Hoc ostendit quod in agro medicina, in innovative progressionem summus finem medicinae cogitationes est adhortatus.

Specie, illud includit: New gene, dapibus et cell an Diagnostic apparatu, New medical Diagnostic Equipment et Reagents, High-Effectus Medical Medica, Vita Support apparatu, Assisted Medical Equipment: Mobile et remotis diagnostic et therapeutic apparatu, summus finem semper AIDS, summus finem implantabilia et interventus products, chirurgicam robots, et altus-terminus chirurgicam apparatu et consumptos, biomedical materiae, additive vestibulum technology et application. Technology Development et Application.

In addition, intelligentes medicinae curatio, medicinae imaginem auxiliaris diagnostic ratio, Medical robot, wearable cogitationes, etc. sunt etiam includitur in consolatione catalogo.

Medicinae in Restricted Category, in Medical cogitationes involved includit: New Construction, Expansion Mercurii-Repleti Vitrum Thermometers, SPHYGMOMANOMETERS, Silver-Mercurius XCIV Amalgam Dental Material, Nova Disposable Syringes, Sanguis, Infra PROMPTU SYRINGES, sanguis TRANSFUS Productio Unitates.

Pharmaceutical Phase-sicco genus includit: Mercurius, repleti speculum thermometris, Sphygmomanometer productionem unitates (XXXI December MMXXV), etc.

Et supra documento et ostendit quod populus imperia provinciarum, autonomia regiones et municipiis directe sub media imperium debet accipere in rationem ipsam progressionem in industries in directionem in directionem investittendo, robora et suscipere et suscipere In progressionem provectus productio facultatem, restringere et eliminare retrorsum productio facultatem ad normam legis, ne caecus obsideri et humilis-gradu repetita constructione et efficaciter promovere optimization et upgrading industriae structuram et efficacius.

 

02

Support pro Promotio et Application de domestice produci medical apparatu

 

Sinis scriptor medical fabrica industria est in booming scaena. Data ostendere quod in MMXXII, Sinis scriptor medical fabrica principalis negotium reditus est pervenit 1.3 trillion Yuan, Sinis scriptor medical fabrica industria in praeteritum quinque annos in mediocris annua compositis incrementum rate of 10.54%.

National Level, Long-Term Support pro progressionem medicinae fabrica industria.

Quod "14. Quinque-Year Plan" pro progressionem medicinae apparatu industria ponit deinceps, focusing in progressionem diagnostic et testing apparatu, medicina et churopeutica apparatu, et filfices apparatu: Salutem cura et semper apparatu, active implantatio ex interventional cogitationes in agro VII major cogitationes.

Per MMXXV, in gradu technology erit permanere ad amplio. Medical apparatu in agro ne, diagnosis, curatio, semper, salutem promotionem, publicae salutem et aliis locis ad consequi magna-scale application. A numerus of altus-finem products ut extracorporeal membrana pulmonis oxygenation machine (ECMO), Luminal Surgery Robot, 7t humanum totum corpus magneticam resonatur curatio ratio, etc. erit applicari.

In promotionem et applicationem de domestice produci medicinae cogitationes etiam datum prioritate attentionem.

In August hoc anno, in statu consilium exsecutiva testimonii considerari et adoptavit actio consilium summus qualitas progressionem medicinae apparatu industria (2023-2025). In conventu illustraverat ut ad magno momenti ad promotionem et applicationem domesticis medicinae apparatu, amplio pertinet subsidium policies et promovere itaterive upgrading domesticis medicinae apparatu.

In loci gradu, multis locis edita progressio progressio ad robora progressionem in medicinae apparatu industria, et introducta supporting mensuras in areas of taxationem et iudicium, applicationem in hospitalium, et mercedem medicinae assecurationis.

General Officium populi imperium de Guangdong provincia edita ad notitiam exsequendam progressio pro promovendi summus qualitas progressionem medicinae fabrica industria in Guangdong provincia. In progressionem metam est ad contendunt ad MMXXV, in medicinae fabrica vestibulum industria reditus compositis annuis incrementum rate of XX% vel magis, in magnitudinem operating reditus CCL billion Yuan Probatus a National Registration certificatorium innovative medicinae cogitationes ad pervenire L; Cultura capitis foro enumerantur conatibus advenio XXXV, enumerantur foro valorem de magis quam C billion Yuan demonstrationem in Enterprise 2-3, annui operating enterprises 3-3 3-3 ducens in ducens enterprises 3-3 Cum annua negotio reditus super X billion Yuan et 5-8 ducens conatibus cum super V billion Yuan; Create a numerus of independens notam backbone conatibus cum internationalis influentiam et formare summus finem medical fabrica industria clusters benchmarked contra mundi primum-genus campester.

General Officium Jiangsu provinciarum imperium edita notitiam in optimizing recensionem et approbatione servicia ad promovere usum innovative medicina et cogitationes et promovere summus qualitas progressionem de pharmaceutical industria (2022-2024), proponens ad firmamentum in orci investigationis , promote the re-engineering of the review and approval process, implement the priority review and approval, expand the resources for review and approval, unimpeded the channels for innovative medicines and consumables to be listed on the network, and promote the innovative medicines and consumables in hospitalium et aliis duodecim. Circularis proponit ad confirma orci investigationis auxilium, promovere reengineering de recensionem et approbatione processus, effectum deducent priori approbatione, expand recensionem et probat resources, et expand recensionem in network, et provenit in in hospitalium .

General Officium De Populi imperium Sichuan provincia edita in notitiam in multis consilium mensuras superiores sustinere summus qualitas progressionem medicinae et curis talis ut confortans Core technology investigationis, supporting auctus investment in R & D Optimizing recensionem et approbatione Services, confirmans promotionem et usum products et augendae financial auxilium.

De toto, Sinis scriptor medical fabrica industria est ingressus novum scaena de "currentem cum, currit in latereide et ducens" et numerus domesticis ducens conatibus qui emerged post alium ad certamen cum multinational gigantibus in variis sub-vestigia. In eodem tempore, in terms of fractionis per key core technologiae, nititur ad altus-finem foro et confortans fonte innovation, ibi adhuc locus adhuc foramen sursum in situ.

 

Hongguan curo vestri salutem.

Vide More Hongguan Product →https://www.hgcmedical.com/products/

Si sunt aliqua necessitates medicorum comsumables, placet liberum contactus nobis.

hongguanmedical@outlook.com


Post tempus: Ian-04-2024